Peripheral blood mononuclear cells expression of miR-200c, miR-125b, miR-27b, miR-203, and miR-155 in patients with significant or insignificant coronary artery stenosis

Peripheral blood mononuclear cells expression of miR-200c, miR-125b, miR-27b, miR-203, and miR-155 in patients with significant or insignificant coronary artery stenosis

Abstract Coronary artery disease (CAD) is one of the principal causes of death worldwide. Among several predisposing factors, inflammation and inflammatory genes play a significant role in disease pathogenesis. Inflammatory microRNAs, small noncoding RNAs involved in regulating inflammation, are pro...

Full description

Bibliographic Details
Main Authors:	Zahra Saadatian, Yaser Mansoori, Lida Nariman-Saleh-Fam, Abdolreza Daraei, Sepideh Zununi Vahed, Shadan Navid, Ziba Nariman-Saleh-Fam
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-10-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-45146-8

Similar Items

Expression of miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-371, miR-372, miR-373, miR-10b, miR-21 and miR-93 in cells of different histotypes of testicular germ cell tumors
by: M. S. Knyazeva, et al.
Published: (2022-03-01)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
by: Qiu Shuwei, et al.
Published: (2013-01-01)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
by: Miruna Nemecz, et al.
Published: (2023-09-01)

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
by: Oshrat Hershkovitz Rokah, et al.
Published: (2012-01-01)

Expression of miR-145, miR-146, and miR-155 in an experimental model of arteriovenous fistula
by: Hugo Laparra-Escareño, et al.
Published: (2022-01-01)

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
by: Paulina López, et al.
Published: (2018-05-01)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
by: Elena Coccia, et al.
Published: (2020-12-01)

MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
by: Sunyoung Park, et al.
Published: (2017-09-01)

miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness
by: Tatiana A. Petrova, et al.
Published: (2022-12-01)

Topographic Distribution of miRNAs (miR-30a, miR-223, miR-let-7a, miR-let-7f, miR-451, and miR-486) in the Plasma Extracellular Vesicles
by: Tatiana Petrova, et al.
Published: (2024-02-01)

Diagnostic performance of miR-21, miR-124, miR-132, and miR-200b serums in post-stroke cognitive impairment patients
by: Mei Yuan, et al.
Published: (2022-06-01)

Alterations in the Expression Profile of Serum miR-155, miR-223, miR-17, miR-200a, miR-205, as well as Levels of Interleukin 6, and Prostaglandins during Endometritis in Arabian Mares
by: Sally Ibrahim, et al.
Published: (2021-06-01)

Changes in miR-124-1, miR-212, miR-132, miR-134, and miR-155 Expression Patterns after 7,12-Dimethylbenz(a)anthracene Treatment in CBA/Ca Mice
by: Andras Tomesz, et al.
Published: (2022-03-01)

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
by: Paola Ulivi, et al.
Published: (2018-01-01)

Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients
by: Farzaneh Raeisi, et al.
Published: (2020-03-01)

Age-Related Exosomal and Endogenous Expression Patterns of miR-1, miR-133a, miR-133b, and miR-206 in Skeletal Muscles
by: Chrystalla Mytidou, et al.
Published: (2021-11-01)

MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
by: Dorota Jesionek-Kupnicka, et al.
Published: (2019-03-01)

The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer
by: Bolayırlı Ibrahim Murat, et al.
Published: (2022-01-01)

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.
by: Kristoffer Unterbruner, et al.
Published: (2018-01-01)

miR-146a, miR-221, and miR-155 are Involved in Inflammatory Immune Response in Severe COVID-19 Patients
by: Noemí Gaytán-Pacheco, et al.
Published: (2022-12-01)

Circulating extracellular miR-22, miR-155, and miR-365 as candidate biomarkers to assess transport-related stress in turkeys
by: C. Lecchi, et al.
Published: (2016-01-01)

miR-21, miR-155, miR-192, and miR-375 Deregulations Related to NF-kappaB Activation in Gastroduodenal Fluid–Induced Early Preneoplastic Lesions of Laryngeal Mucosa In Vivo
by: Clarence T. Sasaki, et al.
Published: (2016-06-01)

Expression pattern of miR-193a, miR122, miR155, miR-15a, and miR146a in peripheral blood mononuclear cells of children with obesity and their relation to some metabolic and inflammatory biomarkers
by: Maryam Behrooz, et al.
Published: (2023-03-01)

Expression of MicroRNAs (miR-15b, miR-16, miR-138, miR-221, and miR-222) as Biomarkers of Endothelial Corpus Cavernosum Dysfunction in a Diabetic Alcoholic Murine Model
by: Ricardo Brianezi Tiraboschi, MD, PhD, et al.
Published: (2021-04-01)

Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
by: Parisa Naeli, et al.
Published: (2017-11-01)

Dysregulated miR-155 and miR-125b Are Related to Impaired B-cell Responses in Down Syndrome
by: Chiara Farroni, et al.
Published: (2018-11-01)

Potential Diagnostic and Prognostic Utility of miR-141, miR-181b1, and miR-23b in Breast Cancer
by: Mohamed Taha, et al.
Published: (2020-11-01)

MiR-146a and miR-155 polymorphisms in Egyptian patients with Behcet’s disease
by: Olfat G. Shaker, et al.
Published: (2021-03-01)

MicroRNA MiR-21 and MiR-155 are new markers for breast cancer
by: M. A. Taipov, et al.
Published: (2014-07-01)

Repression of human activation induced cytidine deaminase by miR-93 and miR-155
by: Holton Nathaniel W, et al.
Published: (2011-08-01)

MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma
by: Thomas Greither, et al.
Published: (2020-08-01)

Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis
by: Taha Aghajanzadeh, et al.
Published: (2023-12-01)

miR-155 in the Resolution of Atherosclerosis
by: Robyn Bruen, et al.
Published: (2019-05-01)

Exosomal let-7e, miR-21-5p, miR-145, miR-146a and miR-155 in Predicting Antidepressants Response in Patients with Major Depressive Disorder
by: Yi-Yung Hung, et al.
Published: (2021-10-01)

Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer
by: Jia Yang, et al.
Published: (2021-09-01)

miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
by: Yasuo Takashima, et al.
Published: (2020-01-01)

Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma.
by: Xi Zeng, et al.
Published: (2012-01-01)

Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors
by: Mostafa Atashbasteh, et al.
Published: (2021-05-01)

Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease
by: Rachel E. Crossland, et al.
Published: (2021-03-01)